CN106565637A - Synthesis method of 3-oxetane acetic acid - Google Patents

Synthesis method of 3-oxetane acetic acid Download PDF

Info

Publication number
CN106565637A
CN106565637A CN201610961453.XA CN201610961453A CN106565637A CN 106565637 A CN106565637 A CN 106565637A CN 201610961453 A CN201610961453 A CN 201610961453A CN 106565637 A CN106565637 A CN 106565637A
Authority
CN
China
Prior art keywords
oxetanes
acetic acid
reaction
synthetic method
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610961453.XA
Other languages
Chinese (zh)
Inventor
陈冬恩
贤少赟
靳跃双
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin Yao Tech Co Ltd
Original Assignee
Tianjin Yao Tech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Yao Tech Co Ltd filed Critical Tianjin Yao Tech Co Ltd
Priority to CN201610961453.XA priority Critical patent/CN106565637A/en
Publication of CN106565637A publication Critical patent/CN106565637A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/04Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D305/06Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention belongs to the fields of organic synthesis and medicine synthesis, and especially relates to a synthesis method of 3-oxetane acetic acid. The synthesis method includes the following steps: (1) performing a reaction to 3-oxetanone and benzyloxycarbonylmethylene triphenylphosphine to obtain an intermediate product 2-(oxetane-3-yl-methylene)benzyl acetate; (2) performing hydrogenation debenzylation to the 2-(oxetane-3-yl-methylene)benzyl acetate to obtain the final product 3-oxetane acetic acid. The reactions in the method can be carried out just at room temperature and reaction conditions are easy to control. The final product can be obtained through re-crystallization and purification, so that the product is high in purity, and deterioration of the product during purification is avoided. The method has reasonable route design, simple process, high yield and short synthesis period, and can provide a high-purity raw material for a subsequent synthesis reaction sufficiently and timely.

Description

A kind of synthetic method of 3- oxetanes acetic acid
Technical field
The invention belongs to organic synthesiss and pharmaceutical synthesis field, more particularly to a kind of synthesis side of 3- oxetanes acetic acid Method.
Background technology
3- oxetanes acetic acid is a kind of important medicine intermediate, be can be widely applied in the design of drug molecule, Its molecular weight is little, unique structure, can derive various downstream product, and tool has been widely used.
However, as ambient air temperature is higher or preserves the reasons such as sealing difference, all easily cause the compound to go bad, so Cause the compound preserve steadily in the long term.Therefore, when needing to use the intermediate during organic synthesiss, it is difficult to directly The chemical reagent is bought, voluntarily can only be synthesized, and be dosed in time in the reaction of next step in post synthesis.However, Still there is no the synthetic method of the document report compound at present.
It would therefore be desirable to design one, raw material is cheap and easy to get, reaction condition is easily-controllable, reaction time is short, and product purity is high Synthetic route, can provide purity higher raw material for follow-up reaction in time.
The content of the invention
The present invention provides to solve technical problem present in known technology that a kind of raw material is cheap and easy to get, reaction condition temperature With synthesis side that is easily-controllable, being easy to the 3- oxetanes acetic acid that purifies and separates, synthetic route are reasonable in design, synthesis cycle is shorter Method.
The present invention is adopted the technical scheme that by solving technical problem present in known technology:A kind of 3- oxa-s ring fourth The synthetic method of alkane acetic acid, the synthetic method are comprised the following steps,
Step one, 3- oxetanones obtain intermediate product 2- (oxa-s with the reaction of (Bian oxygen carbonyl methylene) triphenylphosphine Tetramethylene. -3- methylenes) benzyl acetate, its chemical equation is as follows:
Step 2, the hydrogenation of intermediate product 2- (oxetanes -3- methylenes) benzyl acetate de- Bian is finally produced Thing 3- oxetanes acetic acid, its chemical equation are as follows:
Preferably:The concrete operation method of step one is:3- oxetanones are dissolved in solvents tetrahydrofurane, are cooled to 0-5℃;The tetrahydrofuran solution of (Bian oxygen carbonyl methylene) triphenylphosphine is added dropwise in above-mentioned system, room temperature after rising again naturally Stirring 5-10 hours;TLC monitoring reactions are finished, and above-mentioned system is spin-dried for, and column chromatography purification obtains intermediate product 2- (oxa- ring fourths Alkane -3- methylenes) benzyl acetate.
Preferably:The concrete operation method of step 2 is:Intermediate product 2- (oxetanes -3- methylenes) acetic acid benzyl During ester and Pd/C catalyst add solvents tetrahydrofurane, with hydrogen exchange 3 times, above-mentioned closed system is stirred at room temperature into 4-12 Hour;TLC monitoring reactions are finished, and above-mentioned system is filtered.Filtrate is spin-dried for, and obtains final product 3- oxa-s by recrystallization purification Tetramethylene. acetic acid.
Preferably:In step 2, reaction temperature and post-processing temperature are less than 40 DEG C.
Preferably:0.1%- of the consumption of Pd/C catalyst for reaction substrate mass percent in the second step reaction 1%, reaction pressure is 40-50psi.
Advantages of the present invention and good effect are:All reactions in technique of the present invention can occur anti-at room temperature Should, reaction condition is simple and easy to control;Final products can be obtained by recrystallization purifying, and the purity for obtaining product is higher, and avoids In purge process, product goes bad;Rationally, process is simple, yield are higher, and synthesis cycle is short, can in time, sufficiently for highway route design Highly purified raw material is provided for follow-up synthetic reaction.
Description of the drawings
Fig. 1 is compound 3 in the present invention1HNMR spectrograms;
Fig. 2 is compound 4 in the present invention1HNMR spectrograms.
Specific embodiment
For the content of the invention, feature and effect of the present invention can be further appreciated that, hereby enumerate following examples and describe in detail such as Under:
The synthetic route of the present invention is as follows:
Wherein, the compound 1 being related in the present invention is 3- oxetanones;Compound 2 is (Bian oxygen carbonyl methylene) Triphenylphosphine;Compound 3 is 2- (oxetanes -3- methylenes) benzyl acetate;Compound 4 is 3- oxetanes second Acid;THF is tetrahydrofuran;PE is petroleum ether;EA is ethyl acetate;DCM is dichloromethane;MeOH is methanol;MTBE is methyl Tertbutyl ether.
Embodiment 1:Pilot plant test
The first step:
1 step one pilot plant test of table feeds intake table
Compound Molecular weight Inventory Relative molecular weight Equivalents
1 72 4g 0.056mol 1.1eq
2 410 20.7g 0.051mol 1.0eq
THF - 80mL - -
In this reaction, the inventory of various compounds is as shown in table 1.
Operating procedure:Compound 2 (20.7g), THF (50mL) are added sequentially in 250m L there-necked flasks, by compound 1 (4g) and in 0-5 DEG C of instillation system of THF (30mL) mixed liquor, stirring 5 hours of rising again naturally, TLC (PE:EA=10:1) show former Material (Rf=0.1) reaction is finished, and has product (Rf=0.3) to generate.
Post processing:Above-mentioned system is spin-dried for, column chromatography (PE:EA=20:1) purification obtains product point, is spin-dried for obtaining chemical combination Thing 3 (white solid 8g), yield 65%.
Compound 31HNMR spectrograms are shown in Fig. 1, H-NMR (CDCl3, 400MHz):δ 7.25 (m, 5H), δ 5.58 (m, 1H), δ 5.39 (m, 2H), δ 5.18 (m, 2H), δ 5.05 (s, 2H).
Second step:
2 step 2 pilot plant test of table feeds intake table
Compound Molecular weight Inventory Relative molecular weight Equivalents
3 219 4.2g 0.02mol 1eq
Pd/C - 0.4g - 10w%
THF - 100mL - -
In this reaction, the inventory of various compounds is as shown in table 2.
Operating procedure:Compound 3 (4.2g), THF (100mL), Pd/C 0.4g are added sequentially in 500ml single port bottles, H2Displacement 3 times, is stirred at room temperature 8 hours.TLC(PE:EA=5:1) show that raw material (Rf=0.5) reaction is finished, (DCM:MeOH= 20:1) product (Rf=0.3) generates.
Post processing:Above-mentioned system is filtered, filtrate is spin-dried for, add MTBE 1g/5mL to dissolve which, will wherein insoluble part Divide liquid to separate, soluble fraction is spin-dried for, add PE 1g/2mL recrystallization, obtain compound 4 (white solid 2.1g), yield 91.3%.
Note:Above-mentioned last handling process, cannot heat when being spin-dried for, and heating product can go bad.
Compound 41HNMR spectrograms are shown in Fig. 2, H-NMR (DMSO, 400MHz):δ 4.65 (m, 2H), δ 4.28 (m, 2H), δ 3.21(m,1H),δ2.65(d,2H)。
Embodiment 2:Pilot experiment
The first step:
3 step one pilot experiment of table feeds intake table
Compound Molecular weight Inventory Relative molecular weight Equivalents
1 72 40g 0.56mol 1.1eq
2 410 207g 0.51mol 1.0eq
THF - 800mL - -
In this reaction, the inventory of various compounds is as shown in table 3.
Operating procedure:Compound 2 (207g), THF (500mL) are added sequentially in 2L there-necked flasks, by compound 1 (40g) and in 0-5 DEG C of instillation system of THF (300mL) mixed liquor, stirring 7 hours of rising again naturally, TLC (PE:EA=10:1) show Raw material (Rf=0.1) reaction is finished, and has product (Rf=0.3) to generate.
Post processing:Above-mentioned system is spin-dried for, column chromatography (PE:EA=20:1) purification obtains product point, is spin-dried for obtaining chemical combination Thing 3 (white solid 75g), yield 61%.
Second step:
4 step 2 pilot experiment of table feeds intake table
Compound Molecular weight Inventory Relative molecular weight Equivalents
3 219 50g 0.23mol 1eq
Pd/C - 5g - 10w%
THF - 500mL - -
In this reaction, the inventory of various compounds is as shown in table 4.
Operating procedure:Compound 3 (50g), THF (500mL), Pd/C 5g are added sequentially in lL single port bottles, H2Displacement 3 times, it is stirred at room temperature 10 hours.TLC(PE:EA=5:1) show that raw material (Rf=0.5) reaction is finished, (DCM:MeOH=20:1) There is product (Rf=0.3) to generate.
Post processing:Above-mentioned system is filtered, filtrate is spin-dried for, add MTBE 1g/5mL to dissolve which, will wherein insoluble part Divide liquid to separate, soluble fraction is spin-dried for, add PE 1g/2mL recrystallization, obtain compound 4 (white solid 25g), yield 90.3%.
Note:Above-mentioned last handling process and cannot heat when being spin-dried for, heating product can go bad.
Embodiment 3:Amplification test
The first step:
5 step one amplification test of table feeds intake table
Compound Molecular weight Inventory Relative molecular weight Equivalents
1 72 200g 2.7mol 1.2eq
2 410 1.04kg 2.4mol 1.0eq
THF - 3mL - -
In this reaction, the inventory of various compounds is as shown in table 5.
Operating procedure:Compound 2 (1.04kg), THF (2mL) are added sequentially in 5L there-necked flasks, by compound 1 (200g) and in 0-5 DEG C of instillation system of THF (1L) mixed liquor, stirring 10 hours of rising again naturally, TLC (PE:EA=10:1) show Raw material (Rf=0.1) reaction is finished, and has product (Rf=0.3) to generate.
Post processing:Above-mentioned system is spin-dried for, column chromatography (PE:EA=20:1) purification obtains product point, is spin-dried for obtaining chemical combination Thing 3 (white solid 420g), yield 68.5%.
Second step:
6 step 2 amplification test of table feeds intake table
Compound Molecular weight Inventory Relative molecular weight Equivalents
3 219 400g 1.84mol 1eq
Pd/C - 40g - 10w%
THF - 4L - -
In this reaction, the inventory of various compounds is as shown in table 6.
Operating procedure:Compound 3 (400g), THF (4L), Pd/C 40g are added sequentially in 5L single port bottles, H2Displacement 3 It is secondary, it is stirred at room temperature 10 hours.TLC(PE:EA=5:1) show that raw material (Rf=0.5) reaction is finished, (DCM:MeOH=20:1) have Product (Rf=0.3) is generated.
Post processing:Above-mentioned system is filtered, filtrate is spin-dried for, add MTBE 1g/5mL to dissolve which, will wherein insoluble part Divide liquid to separate, soluble fraction is spin-dried for, add PE 1g/2mL recrystallization, obtain compound 4 (white solid 200g), yield 93.6%.
Note:Above-mentioned last handling process, cannot heat when being spin-dried for, and heating product can go bad.

Claims (5)

1. a kind of synthetic method of 3- oxetanes acetic acid, it is characterised in that:The synthetic method is comprised the following steps,
Step one, 3- oxetanones obtain intermediate product 2- (oxa- ring fourths with the reaction of (Bian oxygen carbonyl methylene) triphenylphosphine Alkane -3- methylenes) benzyl acetate, its chemical equation is as follows:
The hydrogenation of intermediate product 2- (oxetanes -3- methylenes) benzyl acetate de- Bian is obtained final product 3- by step 2 Oxetanes acetic acid, its chemical equation are as follows:
2. the synthetic method of 3- oxetanes acetic acid as claimed in claim 1, it is characterised in that:The concrete operations of step one Method is:3- oxetanones are dissolved in solvents tetrahydrofurane, 0-5 DEG C is cooled to;By (Bian oxygen carbonyl methylene) triphenyl The tetrahydrofuran solution of phosphine is added dropwise in above-mentioned system, and 5-10 hours are stirred at room temperature after rising again naturally;TLC monitoring reactions are finished, Above-mentioned system is spin-dried for, column chromatography purification obtains intermediate product 2- (oxetanes -3- methylenes) benzyl acetate.
3. the synthetic method of 3- oxetanes acetic acid as claimed in claim 2, it is characterised in that:The concrete operations of step 2 Method is:Intermediate product 2- (oxetanes -3- methylenes) benzyl acetates and Pd/C catalyst add solvents tetrahydrofurane In, with hydrogen exchange 3 times, above-mentioned closed system is stirred at room temperature into 4-12 hours;TLC monitoring reactions are finished, by above-mentioned body System filters.Filtrate is spin-dried for, and obtains final product 3- oxetanes acetic acid by recrystallization purification.
4. the synthetic method of 3- oxetanes acetic acid as claimed in claim 3, it is characterised in that:Reaction temperature in step 2 40 DEG C are less than with post-processing temperature.
5. the synthetic method of 3- oxetanes acetic acid as claimed in claim 3, it is characterised in that:In the second step reaction 0.1%-1% of the consumption of Pd/C catalyst for reaction substrate mass percent, reaction pressure is 40-50psi.
CN201610961453.XA 2016-11-04 2016-11-04 Synthesis method of 3-oxetane acetic acid Pending CN106565637A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610961453.XA CN106565637A (en) 2016-11-04 2016-11-04 Synthesis method of 3-oxetane acetic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610961453.XA CN106565637A (en) 2016-11-04 2016-11-04 Synthesis method of 3-oxetane acetic acid

Publications (1)

Publication Number Publication Date
CN106565637A true CN106565637A (en) 2017-04-19

Family

ID=58535739

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610961453.XA Pending CN106565637A (en) 2016-11-04 2016-11-04 Synthesis method of 3-oxetane acetic acid

Country Status (1)

Country Link
CN (1) CN106565637A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010100255A1 (en) * 2009-03-06 2010-09-10 Lipideon Biotechnology Ag Pharmaceutical hypocholesterolemic compositions
CN102712577A (en) * 2009-10-28 2012-10-03 拜耳制药股份公司 Substituted 3-phenylpropionic acids and the use thereof
CN103764658A (en) * 2011-06-17 2014-04-30 安吉奥斯医药品有限公司 Compounds, their pharmaceutical compositions and their uses as IDH1 mutants inhibitors for treating cancers
JP2016056133A (en) * 2014-09-10 2016-04-21 第一三共株式会社 Pyrazolone derivative having cyclic side chain

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010100255A1 (en) * 2009-03-06 2010-09-10 Lipideon Biotechnology Ag Pharmaceutical hypocholesterolemic compositions
CN102712577A (en) * 2009-10-28 2012-10-03 拜耳制药股份公司 Substituted 3-phenylpropionic acids and the use thereof
CN103764658A (en) * 2011-06-17 2014-04-30 安吉奥斯医药品有限公司 Compounds, their pharmaceutical compositions and their uses as IDH1 mutants inhibitors for treating cancers
JP2016056133A (en) * 2014-09-10 2016-04-21 第一三共株式会社 Pyrazolone derivative having cyclic side chain

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
C.D.NENITZESCU ET AL: "SYNTHESES OF α-SUBSTITUTED β-KETO ESTERS", 《RUSS CHEM BULL》 *

Similar Documents

Publication Publication Date Title
CN101356166A (en) Method for preparing 3-hydroxytetrahydrofuran by cyclodehydration
CN107848943A (en) Prepare the new method of chromanone derivatives
CN108276409B (en) Method for preparing medicine and medicine intermediate by continuous solid-liquid-gas three-phase reaction
KR20210108901A (en) Apparatus and method of preparing propylene glycol methyl ether acetate
CN103214446B (en) Asymmetric synthesis method of chromanones derivate
CN103044468A (en) Preparation method of N-(2-pyrazine carbonyl)-L-phenylalanine-L- leucine boracic acid
CN103664821B (en) A kind of benzothiazole compound preparation method based near amino thiophenols cyclisation
CN103788010B (en) Febuxostat intermediate and preparation method thereof
CN106565637A (en) Synthesis method of 3-oxetane acetic acid
CN102146113B (en) Method for synthesizing 16 alpha-hydroxy prednisolone
CN104086525B (en) A kind of there is anti-microbial activity spiral shell [tetralone-tetramethylene sulfide] derivative and synthetic method and application
CN102367230A (en) Method for synthesizing nitrile from aldoxime
CN105503927A (en) Method for synthesizing 3, 6-dihydro-2H-pyrazine (thiazine) furan-4-boric acid ester
CN109456221A (en) A kind of synthetic method of acetanilide derivative
CN102060734B (en) Method for preparing N-(4-ethyoxylcarbonylphenyl)-N'-methyl-N'-phenyl carbonamidine
CN112266364B (en) Preparation method of tetrahydroquinoxaline compound
CN104672179B (en) Preparation method of [(1S)-3-methyl-1-[[(2R)-2-methylepoxyethyl]carbonyl]butyl]tert-butyl carbamate
CN114292248A (en) Method for synthesizing Latemozu intermediate
CN107849003A (en) Prepare the new method of chromanol derivative
CN112159447A (en) Intermediate for synthesizing 2-chloroadenosine, synthesis process thereof and synthesis process of 2-chloroadenosine
CN111056915A (en) Synthesis method of 1, 2-dialkyl-1, 2-diaryl acetylene cyclobutane
CN109369618A (en) Cook different foods in one pot and prepare the chloro- 5-((2-(Nitromethylene of 2-) imidazoline -1- base) methyl) and pyridine method
CN106083624B (en) The one pot process technique of 3- amino -3- phenylpropionic acid esters
CN106478558A (en) A kind of synthetic method of 4 methylol dihydrofuran 2 (3H) ketone
CN105111175A (en) Synthetic method of 3-hydroxy-6-nitroflavone prepared through adopting one-step method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170419